| Application no. and date | 99971317.5 (espacenet) (Federated) (European Patent Register), 19991019 | | Patent/reg. no. and date | DK/EP 1126839, 20070103 | | Publication date | 20010829 | | Priority no. and date | US 183049, 19981030 | | EP pub. no. and date |
EP 1126839 20010829 | | Effective date | | | Applicant/owner | CELGENE CORPORATION, 86 Morris Avenue
Summit, New Jersey 07901, US | | Applicant ref. no. | P1414DKEP | | Inventor | MAN, Hon-Wah, 102 Bermuda Drive
Neshanic Station, NJ 08853, US,
MULLER, George, 250 Windmill Court
Bridgewater, NJ 08807, US | | Representative | HØIBERG P/S, Adelgade 12, 1304 København K | | Opponent | | | IPC Class | A61K 31/4035 (2006.01) , A61K 31/425 (2006.01) , C07D 209/46 (2006.01) , C07D 209/48 (2006.01) , C07D 209/56 (2006.01) , C07D 275/06 (2006.01) | | Title | Substituerede phenethylsulfoner og fremgangsmåde til reduktion af niveauerne af TNF-alfa og PDE-IV | | Int. application no. | US1999024376 | | Int. publication no. | WO2000025777 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
